Volume 15, Number 7—July 2009
Peer Reviewed Report Available Online Only
Meeting on Establishment of Consortium to Study Invasive Salmonelloses in Sub-Saharan Africa
Table
Location | Type of surveillance | Age group | Inclusion criteria | Laboratory tests |
---|---|---|---|---|
Agogo, Republic of Ghana (rural) |
Hospital-based, passive |
>2 m |
History of (72 h) or acute fever and severe disease |
Blood culture, malaria smear |
Kilifi, Kenya (rural) |
Hospital-based, passive |
Pediatric population |
All pediatric admissions |
Blood culture, HIV test, malaria smear |
Bamako, Mali (urban and rural) |
Hospital-based, passive |
0–15 y |
Fever >39°C, clinical syndrome suggestive of invasive bacterial disease |
Blood culture, malaria smear |
Lambaréné, Gabon (rural) |
Hospital-based, passive |
All ages (at physicians request) |
Severe disease with fever |
Blood culture, HIV test, malaria smear |
Muheza, Tanzania (rural) |
Hospital-based, passive |
2 m–14 y |
History of (72 h) or acute fever and severe disease |
Blood culture, HIV test, malaria smear |
Moshi, Tanzania (urban and rural) |
Hospital-based, passive |
>2 mo |
Child: history (72 h) or acute fever and severe disease; Adult: fever >38.0°C (oral) |
Blood culture, HIV test, malaria smear |
Nairobi, Kenya (urban) |
Population-based, active with household- and clinic-based surveillance |
All ages |
Fever >38.5°C or suspected severe pneumonia |
Blood culture, malaria smear, HIV test, NP/OP swabs of patients meeting pneumonia or influenza criteria |
Pemba, Zanzibar (rural) |
Hospital-based, passive |
>2 mo |
Fever >3 d |
Blood culture, HIV test, malaria smear |
Abuja, Nigeria (urban and rural) |
Hospital based, passive |
2–59 mo |
Fever <14 d |
Blood culture, malaria smear, HIV test, APR |
Blantyre, Malawi (urban and rural) |
Hospital-based, passive |
Few neonates; largely >2 mo |
Any nonmalarial febrile illness/ suspicion of invasive bacterial infection |
Blood culture, CSF, HIV test, malaria smear, radiology, sputum smear and culture |
South Africa (countrywide) | Active laboratory surveillance | All ages | NA; all invasive/noninvasive salmonellae isolated | Specimen culture |
*NP, nasopharyngeal; OP, oropharyngeal; APR, acute-phase reactant; CSF, cerebrospinal fluid; NA, not available.
Page created: June 08, 2011
Page updated: June 08, 2011
Page reviewed: June 08, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.